Concepedia

Thomas Loy

TL

5

Publications

280

Citations

5

H-Index

2019

Active since

Affiliations

Nanyang Technological University(Current)

Singapore Immunology Network

National Centre for Infectious Diseases

Agency for Science, Technology and Research

Tan Tock Seng Hospital

Thomas Loy is an author at Nanyang Technological University specializing in humoral immunity, immunodominance, and medicine.

ORCID

Top concepts

Publications per year

2019–2023

5

Publications

5

A Novel, Five-Marker Alternative to CD16–CD14 Gating to Identify the Three Human Monocyte Subsets

Siew‐Min Ong, Karen Wei Weng Teng, Evan W. Newell et al. · Frontiers in Immunology · 2019 · 121 citations · Full text

Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?

Andrew Teo, Hao Dong Tan, Thomas Loy et al. · PLoS Pathogens · 2023 · 63 citations · Full text

Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection

Angéline Rouers, Melissa Hui Yen Chng, Bernett Lee et al. · Cell Reports Medicine · 2021 · 45 citations · Full text

, , +14

A Human Antibody Neutralizes Different Flaviviruses by Using Different Mechanisms

Shuijun Zhang, Thomas Loy, Thiam‐Seng Ng et al. · Cell Reports · 2020 · 32 citations · Full text

CD27hiCD38hi plasmablasts are activated B cells of mixed origin with distinct function

Angéline Rouers, Ramapraba Appanna, Marion Chevrier et al. · iScience · 2021 · 19 citations · Full text

Rows per page

1–5 of 5